Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:22 AM
Ignite Modification Date:
2025-12-25 @ 12:22 AM
NCT ID:
NCT05485558
Eligibility Criteria:
Inclusion Criteria:
* Patients aged 3-18 years with intractable childhood-onset epilepsy.
* All patients are diagnosed to have drug-resistant epilepsy (refractory epilepsy) according to the ILAE definition.
* The subject is willing and able to comply with the study requirements
Exclusion Criteria:
* Any metabolic conditions that might increase the risks associated with trial participation or investigational product administration, such as hepatic enzyme elevation greater than twice normal and/or a GFR \< 60 mL/min/1.73 m2 or electrolyte imbalance.
* Patients with Known allergy to N-acetyl cysteine.
* Patients taking antioxidant and/or anti-inflammatory medications
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
3 Years
Maximum Age:
18 Years
Study:
NCT05485558
Study Brief:
Protocol Section:
NCT05485558